Last reviewed · How we verify
OZ439 Prototype 1
At a glance
| Generic name | OZ439 Prototype 1 |
|---|---|
| Also known as | OZ439 Granules Prototype 1 Granules Formulation |
| Sponsor | Medicines for Malaria Venture |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets (PHASE1)
- Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP) (PHASE1)
- Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- OZ439 Prototype 1 CI brief — competitive landscape report
- OZ439 Prototype 1 updates RSS · CI watch RSS
- Medicines for Malaria Venture portfolio CI